 |
 |
|
|
 |
 |
 |

Ms. Seltzer serves as an Associate
of Aisling Capital. Previously, Ms. Seltzer was an
Associate Director at Schering-Plough, where she held
roles in global licensing, sales, and as the US SP brand
lead for Zetia. While in business development, Ms.
Seltzer was involved in the creation, structuring and
negotiation of several deals with an aggregate value in
the billions, ranging from licensing deals to broad
development and commercialization alliances. Prior to
Schering-Plough, Ms. Seltzer was the Director of
Business Development for Akceli, a biotechnology company
developing cell-based microarrays. Ms. Seltzer began her
career as a Business Analyst for McKinsey & Company.
Ms. Seltzer received her M.B.A. from The Wharton School
at the University of Pennsylvania, where she was a
Palmer Scholar. She received her M.S. and B.S. from Yale
University, awarded cum laude in Molecular Biophysics
and Biochemistry.
|
Dennis Purcell
Steven A. Elms
Andrew Schiff
Dov A. Goldstein
Anthony Y. Sun
Brett I.W. Zbar
Josh Bilenker
Aftab R. Kherani
Stacey D. Seltzer
Christine Lee Ha
Justin Sun
Jacob Van Naarden
Lloyd E. Appel
Andrew P. Nicholson
Robert J. Wenzel
Diana Robinson
Jan Hoerrner
|
|